{"id":340438,"date":"2026-11-05T13:15:12","date_gmt":"2026-11-05T07:45:12","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=340438"},"modified":"2026-11-05T13:15:12","modified_gmt":"2026-11-05T07:45:12","slug":"child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/","title":{"rendered":"3 Child Hospitals Operator, Power Transmission Projects Builder and Pharma Company Stocks With a Strong Future Roadmap: Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories: ROE of 11.4% to 16.9% and FY22 to FY26 revenue CAGR of 13.6% to 31.0%. Prices as of 4 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three child hospital, grid project and drug stocks to watch are Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories. Their return on equity ranges from 11.4% to 16.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 13.6% to 31.0%. Rainbow Children&#8217;s Medicare has the highest return on equity at 16.9%, while Techno Electric &#038; Engineering Company has the fastest revenue growth at 31.0% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Child hospital, grid project and drug stocks let investors follow companies that serve a growing part of the Indian economy. Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories cover a paediatric and maternity hospitals operator, a power transmission projects builder and a pharmaceutical company.<\/p>\n<p>This list covers three child hospital, grid project and drug stocks with complete current figures: Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#What_Are_Child_Hospital_Grid_Project_and_Drug_Stocks\" title=\"What Are Child Hospital, Grid Project and Drug Stocks?\">What Are Child Hospital, Grid Project and Drug Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Child_Hospital_Grid_Project_and_Drug_Stocks_at_a_Glance\" title=\"Child Hospital, Grid Project and Drug Stocks at a Glance\">Child Hospital, Grid Project and Drug Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Why_Do_Child_Hospital_Grid_Project_and_Drug_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Child Hospital, Grid Project and Drug Stocks Have a Strong Roadmap in India?\">Why Do Child Hospital, Grid Project and Drug Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Why_Rainbow_Childrens_Medicare_Features_Among_These_Child_Hospital_Grid_Project_and_Drug_Stocks\" title=\"Why Rainbow Children&#8217;s Medicare Features Among These Child Hospital, Grid Project and Drug Stocks\">Why Rainbow Children&#8217;s Medicare Features Among These Child Hospital, Grid Project and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Why_Techno_Electric_Engineering_Company_Features_Among_These_Child_Hospital_Grid_Project_and_Drug_Stocks\" title=\"Why Techno Electric &#038; Engineering Company Features Among These Child Hospital, Grid Project and Drug Stocks\">Why Techno Electric &#038; Engineering Company Features Among These Child Hospital, Grid Project and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Why_Ipca_Laboratories_Features_Among_These_Child_Hospital_Grid_Project_and_Drug_Stocks\" title=\"Why Ipca Laboratories Features Among These Child Hospital, Grid Project and Drug Stocks\">Why Ipca Laboratories Features Among These Child Hospital, Grid Project and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Rainbow_Childrens_Medicare_vs_Techno_Electric_Engineering_Company_vs_Ipca_Laboratories_on_Key_Financials\" title=\"Rainbow Children&#8217;s Medicare vs Techno Electric &#038; Engineering Company vs Ipca Laboratories on Key Financials\">Rainbow Children&#8217;s Medicare vs Techno Electric &#038; Engineering Company vs Ipca Laboratories on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Key_Risks_to_Check_Before_Investing_in_Child_Hospital_Grid_Project_and_Drug_Stocks\" title=\"Key Risks to Check Before Investing in Child Hospital, Grid Project and Drug Stocks\">Key Risks to Check Before Investing in Child Hospital, Grid Project and Drug Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Final_Thoughts_on_Child_Hospital_Grid_Project_and_Drug_Stocks\" title=\"Final Thoughts on Child Hospital, Grid Project and Drug Stocks\">Final Thoughts on Child Hospital, Grid Project and Drug Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#What_are_child_hospital_grid_project_and_drug_stocks\" title=\"What are child hospital, grid project and drug stocks?\">What are child hospital, grid project and drug stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Which_child_hospital_grid_project_and_drug_stocks_are_covered_in_this_list\" title=\"Which child hospital, grid project and drug stocks are covered in this list?\">Which child hospital, grid project and drug stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Why_do_child_hospital_grid_project_and_drug_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do child hospital, grid project and drug stocks have a strong future roadmap in India?\">Why do child hospital, grid project and drug stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#How_has_Rainbow_Childrens_Medicare_performed_financially\" title=\"How has Rainbow Children&#8217;s Medicare performed financially?\">How has Rainbow Children&#8217;s Medicare performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#How_has_Techno_Electric_Engineering_Company_performed_financially\" title=\"How has Techno Electric &#038; Engineering Company performed financially?\">How has Techno Electric &#038; Engineering Company performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#How_has_Ipca_Laboratories_performed_financially\" title=\"How has Ipca Laboratories performed financially?\">How has Ipca Laboratories performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#What_risks_should_investors_check_before_buying_child_hospital_grid_project_and_drug_stocks\" title=\"What risks should investors check before buying child hospital, grid project and drug stocks?\">What risks should investors check before buying child hospital, grid project and drug stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/child-hospitals-operator-power-transmission-projects-builder-and-pharma-company-stocks-roadmap-headland-list\/#Is_this_list_of_child_hospital_grid_project_and_drug_stocks_investment_advice\" title=\"Is this list of child hospital, grid project and drug stocks investment advice?\">Is this list of child hospital, grid project and drug stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Child_Hospital_Grid_Project_and_Drug_Stocks\"><\/span><strong>What Are Child Hospital, Grid Project and Drug Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Child hospital, grid project and drug stocks are listed companies that run paediatric, neonatal and maternity hospitals, build power transmission and distribution projects, and make formulations and active ingredients sold in India and overseas. Their earnings depend on patient volumes, grid projects and drug orders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Child_Hospital_Grid_Project_and_Drug_Stocks_at_a_Glance\"><\/span><strong>Child Hospital, Grid Project and Drug Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/rainbow\/rainbow-children's-medicare-ltd-share-price-today\">Rainbow Children&#8217;s Medicare<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,279.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12,554<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/technoe\/techno-electric-and-engineering-company-ltd-share-price-today\">Techno Electric &#038; Engineering Company<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">884.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,943<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,972<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">46,050<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.10<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Rainbow Children&#8217;s Medicare and Ipca Laboratories trade at a P\/E below the industry P\/E, while Techno Electric &#038; Engineering Company trades above it, which reflects the growth the market already expects. Readers comparing child hospital, grid project and drug stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in child hospital, grid project and drug stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Child_Hospital_Grid_Project_and_Drug_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Child Hospital, Grid Project and Drug Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Child hospital, grid project and drug stocks have a strong roadmap in India because growing demand for specialised child and maternity care, large grid investment and steady medicine use keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Child care hospitals.<\/strong> Families seek trusted maternity and child care.<\/li>\n<li><strong>Grid projects.<\/strong> Utilities add lines and substations.<\/li>\n<li><strong>Pharma.<\/strong> Formulations reach more markets.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Rainbow_Childrens_Medicare_Features_Among_These_Child_Hospital_Grid_Project_and_Drug_Stocks\"><\/span><strong>Why Rainbow Children&#8217;s Medicare Features Among These Child Hospital, Grid Project and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the child hospital, grid project and drug stocks on this list, Rainbow Children&#8217;s Medicare operates paediatric, neonatal and maternity hospitals under the Rainbow Children&#8217;s Hospital and BirthRight by Rainbow brands, with clusters in Hyderabad, Bengaluru, Chennai and Delhi NCR.<\/p>\n<p>In the June 2026 quarter, revenue grew 29.4% year on year to Rs 483 crore, while net profit rose 16.2% to Rs 62.5 crore. Revenue rose from Rs 993 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%.<\/p>\n<p>Net profit grew from Rs 139 crore in FY22 to Rs 282 crore in FY26, which works out to a compound annual growth rate of 19.4%. The company has a return on equity of 16.9%, a debt to equity ratio of 0.54 and a market capitalisation of Rs 12,554 crore. The stock trades at a P\/E of 43.2, below the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company adds hospitals in a cluster model, so each new site draws referrals from nearby facilities. Its focus on child and women&#8217;s healthcare is a defined niche where few organised competitors operate at scale, which helps both pricing and brand recall.<\/p>\n<p><strong>What to watch:<\/strong> Monitor how fast new clusters in Delhi NCR and other regions reach breakeven.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Techno_Electric_Engineering_Company_Features_Among_These_Child_Hospital_Grid_Project_and_Drug_Stocks\"><\/span><strong>Why Techno Electric &#038; Engineering Company Features Among These Child Hospital, Grid Project and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the health, power and pharma shares on this list, Techno Electric &#038; Engineering Company builds power transmission and distribution infrastructure and also owns and operates wind power assets and data centre capacity.<\/p>\n<p>The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P\/E of 25.4, above the industry P\/E of 22.7.<\/p>\n<p>Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.<\/p>\n<p><strong>What to watch:<\/strong> Watch the build-out of data centre capacity and the timing of large transmission orders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Ipca_Laboratories_Features_Among_These_Child_Hospital_Grid_Project_and_Drug_Stocks\"><\/span><strong>Why Ipca Laboratories Features Among These Child Hospital, Grid Project and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Ipca Laboratories is a Mumbai-based pharmaceutical company that makes formulations and active ingredients, with leading brands in pain management, anti-malarials, cardiovascular and anti-infective therapies.<\/p>\n<p>Revenue rose from Rs 5,896 crore in FY22 to Rs 9,821 crore in FY26, a compound annual growth rate of 13.6%. Net profit grew from Rs 911 crore in FY22 to Rs 1,191 crore in FY26, which works out to a compound annual growth rate of 6.9%.<\/p>\n<p>In the June 2026 quarter, revenue grew 20.2% year on year to Rs 2,813 crore, while net profit rose 80.4% to Rs 423 crore. The company has a return on equity of 14.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 46,050 crore. The stock trades at a P\/E of 33.5, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company has strong domestic brands and a vertically integrated base in active ingredients, which supports quality and cost control. It is expanding its chronic and specialty portfolio and widening its footprint in regulated export markets.<\/p>\n<p><strong>What to watch:<\/strong> Monitor the growth of the branded domestic business and the capacity utilisation of its active ingredient plants.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Rainbow_Childrens_Medicare_vs_Techno_Electric_Engineering_Company_vs_Ipca_Laboratories_on_Key_Financials\"><\/span><strong>Rainbow Children&#8217;s Medicare vs Techno Electric &#038; Engineering Company vs Ipca Laboratories on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three child hospital, grid project and drug stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Rainbow Children&#8217;s Medicare<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">993<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,747<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">282<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Techno Electric &#038; Engineering Company<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,154<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,401<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">449<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Ipca Laboratories<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,896<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,821<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,191<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Rainbow Children&#8217;s Medicare posts the highest return on equity in this group at 16.9%. Ipca Laboratories has the largest FY26 revenue at Rs 9,821 crore, and Techno Electric &#038; Engineering Company shows the fastest revenue growth with a 31.0% compound annual rate. A useful habit with child hospital, grid project and drug stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several paediatric care, substation and formulation stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Rainbow Children&#8217;s Medicare<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">373<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">483<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Techno Electric &#038; Engineering Company<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">574<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">659<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Ipca Laboratories<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,342<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,813<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.2%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Child_Hospital_Grid_Project_and_Drug_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Child Hospital, Grid Project and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these child hospital, grid project and drug stocks, the main points are: Long-term health, power and pharma shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio. Tracking promoter holding and management commentary adds context when you study health, power and pharma shares.<\/p>\n<ul>\n<li><strong>Capacity ramp up.<\/strong> New hospitals take time to fill beds and reach full returns.<\/li>\n<li><strong>Component costs.<\/strong> Copper, chips and other inputs can move margins.<\/li>\n<li><strong>Valuation levels.<\/strong> Some of these companies trade at high earnings multiples, so growth must continue to justify them.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter child hospital, grid project and drug stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Child_Hospital_Grid_Project_and_Drug_Stocks\"><\/span><strong>Final Thoughts on Child Hospital, Grid Project and Drug Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Child hospital, grid project and drug stocks reward investors who follow demand trends, order books and margins together. Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories each have a clear plan to grow. Based on the 4 November 2026 close, Rainbow Children&#8217;s Medicare trades at Rs 1,279.6, Techno Electric &#038; Engineering Company at Rs 884.4 and Ipca Laboratories at Rs 1,972. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these child hospital, grid project and drug stocks to a watchlist. Peer comparison is the simplest way to judge child hospital, grid project and drug stocks, because sector averages show whether a company&#8217;s margins and returns are ordinary or exceptional.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track child hospital, grid project and drug stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_child_hospital_grid_project_and_drug_stocks\"><\/span><strong>What are child hospital, grid project and drug stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Child hospital, grid project and drug stocks are listed companies that run paediatric, neonatal and maternity hospitals, build power transmission and distribution projects, and make formulations and active ingredients sold in India and overseas. Their earnings depend on patient volumes, grid projects and drug orders. This list looks at three of them, Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_child_hospital_grid_project_and_drug_stocks_are_covered_in_this_list\"><\/span><strong>Which child hospital, grid project and drug stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories. Based on the 4 November 2026 close, Rainbow Children&#8217;s Medicare traded at Rs 1,279.6, Techno Electric &#038; Engineering Company at Rs 884.4 and Ipca Laboratories at Rs 1,972. Their return on equity ranges from 11.4% to 16.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 13.6% to 31.0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_child_hospital_grid_project_and_drug_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do child hospital, grid project and drug stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Child hospital, grid project and drug stocks have a strong roadmap in India because growing demand for specialised child and maternity care, large grid investment and steady medicine use keep widening the market for these companies. The main drivers are as follows. Child care hospitals. Families seek trusted maternity and child care. Grid projects. Utilities add lines and substations. Pharma. Formulations reach more markets. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Rainbow_Childrens_Medicare_performed_financially\"><\/span><strong>How has Rainbow Children&#8217;s Medicare performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 993 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 139 crore in FY22 to Rs 282 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 29.4% year on year to Rs 483 crore, while net profit rose 16.2% to Rs 62.5 crore. The company has a return on equity of 16.9%, a debt to equity ratio of 0.54 and a market capitalisation of Rs 12,554 crore. The stock trades at a P\/E of 43.2, below the industry P\/E of 59.6. Looking ahead, the company adds hospitals in a cluster model, so each new site draws referrals from nearby facilities. Its focus on child and women&#8217;s healthcare is a defined niche where few organised competitors operate at scale, which helps both pricing and brand recall.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Techno_Electric_Engineering_Company_performed_financially\"><\/span><strong>How has Techno Electric &#038; Engineering Company performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore. The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P\/E of 25.4, above the industry P\/E of 22.7. Looking ahead, strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Ipca_Laboratories_performed_financially\"><\/span><strong>How has Ipca Laboratories performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 5,896 crore in FY22 to Rs 9,821 crore in FY26, a compound annual growth rate of 13.6%. Net profit grew from Rs 911 crore in FY22 to Rs 1,191 crore in FY26, which works out to a compound annual growth rate of 6.9%. In the June 2026 quarter, revenue grew 20.2% year on year to Rs 2,813 crore, while net profit rose 80.4% to Rs 423 crore. The company has a return on equity of 14.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 46,050 crore. The stock trades at a P\/E of 33.5, below the industry P\/E of 36.0. Looking ahead, the company has strong domestic brands and a vertically integrated base in active ingredients, which supports quality and cost control. It is expanding its chronic and specialty portfolio and widening its footprint in regulated export markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_child_hospital_grid_project_and_drug_stocks\"><\/span><strong>What risks should investors check before buying child hospital, grid project and drug stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying child hospital, grid project and drug stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Component costs. Copper, chips and other inputs can move margins. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_child_hospital_grid_project_and_drug_stocks_investment_advice\"><\/span><strong>Is this list of child hospital, grid project and drug stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are child hospital, grid project and drug stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Child hospital, grid project and drug stocks are listed companies that run paediatric, neonatal and maternity hospitals, build power transmission and distribution projects, and make formulations and active ingredients sold in India and overseas. Their earnings depend on patient volumes, grid projects and drug orders. This list looks at three of them, Rainbow Children's Medicare, Techno Electric & Engineering Company and Ipca Laboratories, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which child hospital, grid project and drug stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Rainbow Children's Medicare, Techno Electric & Engineering Company and Ipca Laboratories. Based on the 4 November 2026 close, Rainbow Children's Medicare traded at Rs 1,279.6, Techno Electric & Engineering Company at Rs 884.4 and Ipca Laboratories at Rs 1,972. Their return on equity ranges from 11.4% to 16.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 13.6% to 31.0%.\"}},{\"@type\":\"Question\",\"name\":\"Why do child hospital, grid project and drug stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Child hospital, grid project and drug stocks have a strong roadmap in India because growing demand for specialised child and maternity care, large grid investment and steady medicine use keep widening the market for these companies. The main drivers are as follows. Child care hospitals. Families seek trusted maternity and child care. Grid projects. Utilities add lines and substations. Pharma. Formulations reach more markets. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Rainbow Children's Medicare performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 993 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew from Rs 139 crore in FY22 to Rs 282 crore in FY26, which works out to a compound annual growth rate of 19.4%. In the June 2026 quarter, revenue grew 29.4% year on year to Rs 483 crore, while net profit rose 16.2% to Rs 62.5 crore. The company has a return on equity of 16.9%, a debt to equity ratio of 0.54 and a market capitalisation of Rs 12,554 crore. The stock trades at a P\/E of 43.2, below the industry P\/E of 59.6. Looking ahead, the company adds hospitals in a cluster model, so each new site draws referrals from nearby facilities. Its focus on child and women's healthcare is a defined niche where few organised competitors operate at scale, which helps both pricing and brand recall.\"}},{\"@type\":\"Question\",\"name\":\"How has Techno Electric & Engineering Company performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore. The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P\/E of 25.4, above the industry P\/E of 22.7. Looking ahead, strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.\"}},{\"@type\":\"Question\",\"name\":\"How has Ipca Laboratories performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 5,896 crore in FY22 to Rs 9,821 crore in FY26, a compound annual growth rate of 13.6%. Net profit grew from Rs 911 crore in FY22 to Rs 1,191 crore in FY26, which works out to a compound annual growth rate of 6.9%. In the June 2026 quarter, revenue grew 20.2% year on year to Rs 2,813 crore, while net profit rose 80.4% to Rs 423 crore. The company has a return on equity of 14.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 46,050 crore. The stock trades at a P\/E of 33.5, below the industry P\/E of 36.0. Looking ahead, the company has strong domestic brands and a vertically integrated base in active ingredients, which supports quality and cost control. It is expanding its chronic and specialty portfolio and widening its footprint in regulated export markets.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying child hospital, grid project and drug stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying child hospital, grid project and drug stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Component costs. Copper, chips and other inputs can move margins. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of child hospital, grid project and drug stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Child Hospital, Grid Project and Drug Stocks with a strong future roadmap: Rainbow Children&#8217;s Medicare, Techno Electric &#038; Engineering Company and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 4 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":340437,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,20573,20574,20311,13964,20575,20485,9128,20576],"class_list":["post-340438","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-child-hospital","tag-grid-project-and-drug-stocks","tag-health","tag-ipca-laboratories","tag-paediatric-care","tag-power-and-pharma-shares","tag-rainbow-childrens-medicare","tag-substation-and-formulation-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["340437"],"rank_math_title":["Child Hospital, Grid Project and Drug Stocks"],"rank_math_description":["Compare 3 child hospital, grid project and drug stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 4 Nov 2026."],"rank_math_focus_keyword":["child hospital, grid project and drug stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-child-hospitals-operator-power-transmission-projects-builder-and-pharma.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=340438"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340438\/revisions"}],"predecessor-version":[{"id":340439,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/340438\/revisions\/340439"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/340437"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=340438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=340438"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=340438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}